Evidence map›Paper›PMID 25614732›Full record

ReviewNuclear receptor signaling2014

Nuclear Receptor Signaling: a home for nuclear receptor and coregulator signaling research.

Neil J McKenna, Ronald M Evans, Bert W O'Malley

Abstract readReview
In one paragraph

Review in Nuclear receptor signaling, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Androgens and Selective Androgen Receptor Modulators to Treat Functional Limitations Associated With Aging and Chronic Disease.The journals of gerontology. Series A, Biological sciences and medical sciences · 2023
    Review
  3. Article
  4. Review
  5. Sex, metabolism and health.Molecular metabolism · 2018
    Review
  6. Article
  7. Brain nuclear receptors and body weight regulation.The Journal of clinical investigation · 2017
    Review
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Neil J McKennaNuclear Receptor Signaling Atlas (NJM, RME, BWO) and Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030 (NJM, BWO), and Gene Expression Laboratory, The Salk Institute for Biological Studies, La Jolla, CA 92037 (RME).
Ronald M EvansNuclear Receptor Signaling Atlas (NJM, RME, BWO) and Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030 (NJM, BWO), and Gene Expression Laboratory, The Salk Institute for Biological Studies, La Jolla, CA 92037 (RME).
Bert W O'MalleyNuclear Receptor Signaling Atlas (NJM, RME, BWO) and Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030 (NJM, BWO), and Gene Expression Laboratory, The Salk Institute for Biological Studies, La Jolla, CA 92037 (RME).

Funding

HORMONAL REGULATION OF MAMMALIAN GENE EXPRESSIONR37DK057978 · NIDDK · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI EVANS, RONALD M · 2000 to 2019
$16.0M
EXPANSION OF NURSA TRANSCRIPTOMINE ANNOTATIONU24DK097748 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI EVANS, RONALD M, MCKENNA, NEIL · 2012 to 2017
$9.2M
Spatial Regulation of Developmental Gene ExpressionR01HL105278 · NHLBI · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI EVANS, RONALD M · 2011 to 2019
$4.0M
NIDDK NIH HHS U24 DK097748NIDDK NIH HHS U24DK097748NIDDK NIH HHS U24DK097748-S1
6 · The paper itself

Abstract

The field of nuclear receptor and coregulator signaling has grown into one of the most active and interdisciplinary in eukaryotic biology. Papers in this field are spread widely across a vast number of journals, which complicates the task of investigators in keeping current with the literature in the field. In 2003, we launched Nuclear Receptor Signaling as an Open Access reviews, perspectives and methods journal for the nuclear receptor signaling field. Building on its success and impact on the community, we have added primary research and dataset articles to this list of article categories, and we now announce the re-launch of the journal this month. Here we will summarize the rationale that informed the creation and expansion of the journal, and discuss the possibilities for its future development.

Indexed as

Periodicals as TopicReceptors, Cytoplasmic and NuclearResearchSignal TransductionDatabases, FactualReceptors, Cytoplasmic and Nuclear

Identifiers

PMID25614732
PMCPMC4303009

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.